Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medicare Rx Price Negotiation Gets Finance Cmte. Ally With Sen. Stabenow

Executive Summary

Supporters of government price negotiations for Medicare Part D prescription drugs will have another Senate Finance Committee ally in the next Congress, with the appointment of Sen. Debbie Stabenow (D-Mich.)

You may also be interested in...



FDA Will Refer Potentially Anti-Competitive Citizen Petitions To FTC

Questionable citizen petitions will be referred to the Federal Trade Commission, FDA says in a report made to House and Senate appropriations committees

FDA Faces Pricing Pressure As Generic Drug User Fee Debate Begins

Emerging discussions on the creation of a user fee program for generic drug review place FDA in the awkward position of potentially being seen as an arbiter of drug prices - at least indirectly

Rx Importation May Be Price For Moving McClellan To CMS

Senate reimportation advocates want answers from FDA Commissioner McClellan on drug pricing issues before they will consider his nomination to head CMS

UsernamePublicRestriction

Register

OM006051

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel